Iran has made remarkable strides in its nuclear program, unveiling a total of 150 scientific and technological advancements over the past year, as announced by the Atomic Energy Organization of Iran (AEOI). During an event held in Tehran to mark National Nuclear Technology Day, AEOI President Mohammad Eslami highlighted 15 significant breakthroughs in the field of radiopharmaceuticals. These achievements have positioned Iran among the top three leaders globally in this area.
Eslami specifically emphasized Iran’s innovative use of alpha particles for cancer treatment as a noteworthy accomplishment, underscoring the country’s advancements in medical applications of nuclear technology. Furthermore, the AEOI plans to generate 20,000 megawatts of nuclear electricity in the coming years through new power plants in the southern region of Iran.
Despite global concerns about the military implications of Tehran’s nuclear activities, Iran maintains that its nuclear program is primarily focused on peaceful purposes such as power generation and medical research. However, ongoing inspections by the International Atomic Energy Agency have revealed undisclosed nuclear facilities and materials in Iran, casting doubt on the country’s intentions and compliance with nonproliferation agreements.
Moreover, Iran’s advancements in long-range ballistic missile technology capable of delivering nuclear warheads have fueled apprehensions that its nuclear ambitions may extend beyond peaceful objectives. The 2015 nuclear deal known as the Joint Comprehensive Plan of Action has faced uncertainty since the US withdrew in 2018. Current discussions held in Vienna aimed at reviving the agreement are yet to yield significant progress.
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/SHZS63UVUVBIHKYXCRRMDXZQHI.jpg)
